Drug Type Diagnostic radiopharmaceuticals |
Synonyms- |
Target |
Mechanism ERs modulators(Estrogen receptors modulators), ESR2 antagonists(Estrogen receptor beta antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Contrast agents | Preclinical | NL | 01 Dec 2016 | |
Neoplasms | Preclinical | NL | 01 Dec 2016 |